RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.
06 juil. 2022 08h00 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc.,...
Worldwide Macular Degeneration Treatment Industry to 2027 - Featuring Iveric Bio, Novartis and Panoptica Among Others
09 juin 2022 08h03 HE
|
Research and Markets
Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
29 avr. 2022 11h36 HE
|
Ocugen
MALVERN, Pa., April 29, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene therapies, biologicals and...
Anterior Uveitis Treatment Market (2021 - 2026): Key Global Players Include Abbvie, Novartis and Regeneron
10 mars 2022 04h08 HE
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Anterior Uveitis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
Global Bionic Eye Market Research Report 2021 Featuring Nidek, Nano Retina, MetaModa, Pixium Vision, Monash Vision, iBionics & Optobionics
10 mars 2022 04h03 HE
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Global Bionic Eye Market, By Type (Implant v/s External), By Technology (Electronic v/s Mechanical), By End User (Hospitals, Ophthalmic Clinics,...
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
09 déc. 2021 07h28 HE
|
Ocugen
Gene therapy candidate has potential to address a large number of retinitis pigmentosa and Leber congenital amaurosis gene mutations with a single productTrial to start in Q1 2022 will enroll patients...
Insights on the Artificial Cornea and Corneal Implant Global Market to 2028 - Shortage of Corneal Donors Provides Opportunities for Corneal Implant Manufacturers
04 nov. 2021 08h23 HE
|
Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "Artificial Cornea and Corneal Implant Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type; Transplant Type; Disease Indication; End...
Insights on the Automated Visual Field Analyzer Global Market to 2028 - Size, Share & Trends Analysis Report
30 sept. 2021 07h33 HE
|
Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Global Automated Visual Field Analyzer Market Size, Share & Trends Analysis Report by Product (Static, Kinetic), by End Use (Hospitals, Ophthalmic...
Worldwide Diabetic Retinopathy Industry to 2026 - by Type, Treatment Type, End-user and Region
16 août 2021 08h38 HE
|
Research and Markets
Dublin, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The "Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
29 avr. 2021 05h13 HE
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...